Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Huachansu mediates cell death in non-Hodgkin's lymphoma by induction of caspase-3 and inhibition of MAP kinase. | Int J Oncol | 2015 | 26062471 | PubTator, text mining | PubMed |
| A de novo 1.58 Mb deletion, including MAP2K6 and mapping 1.28 Mb upstream to SOX9, identified in a patient with Pierre Robin sequence and osteopenia with multiple fractures. | Am J Med Genet A | 2015 | 26059046 | PubTator, text mining | PubMed |
| Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity. | Biochem Biophys Res Commun | 2015 | 26056008 | PubTator, text mining | PubMed |
| Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism. | Arch Toxicol | 2015 | 26047665 | PubTator, text mining | PubMed |
| The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors. | Sci Signal | 2015 | 26038599 | PubTator, text mining | PubMed |
| The case for inhibiting p38 mitogen-activated protein kinase in heart failure. | Front Pharmacol | 2015 | 26029107 | PubTator, text mining | PubMed |
| A Comprehensive Profile of ChIP-Seq-Based Olig2 Target Genes in Motor Neuron Progenitor Cells Suggests the Possible Involvement of Olig2 in the Pathogenesis of Amyotrophic Lateral Sclerosis. | J Cent Nerv Syst Dis | 2015 | 26023283 | PubTator, text mining | PubMed |
| Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents. | Clin Cancer Res | 2015 | 26023085 | PubTator, text mining | PubMed |
| KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine. | Cancer Res | 2015 | 25968887 | PubTator, text mining | PubMed |
| An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cells. | Virology | 2015 | 25965802 | PubTator, text mining | PubMed |
| Characterization of Mutants of Human Small Heat Shock Protein HspB1 Carrying Replacements in the N-Terminal Domain and Associated with Hereditary Motor Neuron Diseases. | PLoS One | 2015 | 25965061 | PubTator, text mining | PubMed |
| p38MAPK Signaling Enhances Glycolysis Through the Up-Regulation of the Glucose Transporter GLUT-4 in Gastric Cancer Cells. | Cell Physiol Biochem | 2015 | 25925563 | PubTator, text mining | PubMed |
| PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness. | BMC Cancer | 2015 | 25924946 | PubTator, text mining | PubMed |
| p66Shc as a switch in bringing about contrasting responses in cell growth: implications on cell proliferation and apoptosis. | Mol Cancer | 2015 | 25890053 | PubTator, text mining | PubMed |
| Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. | Genome Biol | 2015 | 25887922 | PubTator, text mining | PubMed |
| MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27. | PLoS One | 2015 | 25874627 | PubTator, text mining | PubMed |
| Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway. | PLoS One | 2015 | 25856433 | PubTator, text mining | PubMed |
| Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations. | Psychopharmacology (Berl) | 2015 | 25843748 | PubTator, text mining | PubMed |
| Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. | Drug Des Devel Ther | 2015 | 25834400 | PubTator, text mining | PubMed |
| Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells. | Drug Des Devel Ther | 2015 | 25834399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=68